ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARP Annual Meeting 2019

Abstract Number: 2024

Genetics of Longitudinal Kidney Function in Children and Adults with Systemic Lupus Erythematosus

Thai-Son Tang1, Declan Webber 2, Jingjing Cao 3, Daniela Dominguez 4, Dafna Gladman 5, Andrea Knight 6, Deborah Levy 7, Lawrence Ng 4, Andrew D. Paterson 8, Earl D. Silverman 9, Zahi Touma 10, Murray Urowitz 10, Joan Wither 11, Eleanor M. Pullenayegum 12 and Linda Hiraki 13, 1Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 2University of Toronto, The Hospital for Sick Children, Toronto, Canada, 3Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Canada, 4Division of Rheumatology, The Hospital for Sick Children, Toronto, Canada, 5Toronto Western Hospital, Toronto, Canada, Toronto, ON, Canada, 6Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 7Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 8Genetics & Genome Biology, The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 9Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Canada, 10University Health Network, University of Toronto, Toronto, ON, Canada, 11University Health Network, Krembil Research Institute, Toronto, ON, Canada, 12Child Health Evaluative Sciences, The Hospital for Sick Children, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada, 13Division of Rheumatology, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, Toronto, Canada

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARP Annual Meeting 2019

Keywords: lupus nephritis and longitudinal studies, Systemic lupus erythematosus (SLE)

Session Information

Date: Tuesday, November 12, 2019

Title: SLE – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Genetics influences kidney function (estimated glomerular filtration rate (eGFR)), systemic lupus erythematosus (SLE) and lupus nephritis (LN) risk. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) associated with eGFR in the general population as well as SLE. However, few loci have been identified and replicated for LN risk, in part due to heterogeneity with LN. Using quantitative, repeated eGFR measures as opposed to binary LN may be more informative in detecting LN genetic loci. Our objective was to demonstrate repeated eGFR measures as potentially informative measures in GWAS by showing an association exists between SNPs associated with eGFR and SLE on (1) mean and (2) variance of eGFR.

Methods: We included 1167 patients followed in Toronto Lupus Clinics from SickKids and/or the Toronto Western Hospital. Patients met ≥4 ACR and/or SLICC criteria for SLE and were genotyped on the Illumina MEGA or Omni1-Quad arrays. Ungenotyped SNPs were imputed. Non-HLA additive genetic risk scores (GRS) were calculated for SLE, and for eGFR, using published GWAS weights for loci that met p < 5×10-8. LN was confirmed by renal biopsy. Longitudinal, prospectively collected clinical and laboratory data, including serum creatinine, were extracted from lupus databases. eGFR was calculated using the CKD-EPI (≥18y), and Schwartz equations (< 18y). We tested the effect of SLE-GRS and eGFR-GRS with respect to (1) eGFR mean using linear mixed models and (2) eGFR variance through Gamma regression of squared-ordinary least squares jackknife residuals in R. Models included a time-varying indicator for eGFR taken as a child or adult.

Results: Our cohort included 567 (47%) patients with childhood-onset SLE (cSLE) and 615 (53%) adult-onset SLE (aSLE) with a total of 36,258 eGFR measures (23,926 measures (66%) during aSLE). Median follow-up time was 7.52 years [IQR: 3.92, 15.25 years] (Table). The majority were female (87%) and of European ancestry (48%). There was a median lag of 77 days [IQR: 0, 1193 days] between SLE diagnosis and first visit. Under a t-test of independence, we observed lower within-person mean eGFR (p < 0.001) and higher within-person eGFR variance (p < 0.001) in patients with LN compared to those without LN. From linear mixed models and Gamma regression, a unit increase in eGFR-GRS was associated with a 0.60 mL/min/1.73 m2 increase in eGFR (0.60; 95% CI: [0.24, 0.96]; p = 0.001) and a 2% increase in eGFR variance (1.02; 95% CI: [1.02, 1.03]; p < 0.001). A unit increase in SLE-GRS was associated with a 1.28 mL/min/1.73 m2 decrease in eGFR (-1.28; 95% CI: [-2.42, -0.13]; p = 0.029) and a 4% increase in eGFR variance (1.04 95% CI: [1.01, 1.06]; p < 0.001).

Conclusion: Using a large number of repeated eGFR measures taken from people with aSLE and cSLE, we observed that as expected, patients with LN had both lower mean eGFR and higher variability in eGFR, when compared to patients without LN. We demonstrated that eGFR and SLE loci are influencing (1) eGFR mean and (2) eGFR variance in SLE patients. This suggests that longitudinal eGFR measures may be more informative outcomes than binary LN categories for identifying genetics of kidney disease in SLE.

Summary statistics of patient-level laboratory, demographic and clinical characteristics collected during follow-up between LN and non-LN patients.


Disclosure: T. Tang, None; D. Webber, None; J. Cao, None; D. Dominguez, None; D. Gladman, AbbVie, 2, 5, Amgen, 2, 5, BMS, 5, Celgene, 2, 5, Eli Lilly, 2, 5, Galapagos, 5, Galapagos NV, 5, Gilead, 5, GSI, 5, Janssen, 5, Janssen Research & Development, LLC, 2, Novartis, 2, 5, Pfizer, 2, 5, UCB, 2, 5; A. Knight, None; D. Levy, None; L. Ng, None; A. Paterson, None; E. Silverman, None; Z. Touma, Janssen Research & Development, LLC, 2, Janssen Scientific Affairs, LLC, 2; M. Urowitz, Janssen Research & Development, LLC, 2, UCB Pharma, 9; J. Wither, None; E. Pullenayegum, None; L. Hiraki, None.

To cite this abstract in AMA style:

Tang T, Webber D, Cao J, Dominguez D, Gladman D, Knight A, Levy D, Ng L, Paterson A, Silverman E, Touma Z, Urowitz M, Wither J, Pullenayegum E, Hiraki L. Genetics of Longitudinal Kidney Function in Children and Adults with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/genetics-of-longitudinal-kidney-function-in-children-and-adults-with-systemic-lupus-erythematosus/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/genetics-of-longitudinal-kidney-function-in-children-and-adults-with-systemic-lupus-erythematosus/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology